Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1993 Aug;159(2):189–192.

Use of aprotinin to reduce intraoperative bleeding.

T W Feeley 1, L A Rinsky 1
PMCID: PMC1022232  PMID: 7692676

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alajmo F., Calamai G., Perna A. M., Melissano G., Pretelli P., Palmarini M. F., Carbonetto F., Noferi D., Boddi V., Palminiello A. High-dose aprotinin: hemostatic effects in open heart operations. Ann Thorac Surg. 1989 Oct;48(4):536–539. doi: 10.1016/s0003-4975(10)66857-9. [DOI] [PubMed] [Google Scholar]
  2. Beck O. J., Oeckler R. Frühdiagnose und Therapie der Aneurysma-blutungen. MMW Munch Med Wochenschr. 1981 Apr 3;123(14):561–564. [PubMed] [Google Scholar]
  3. Bidstrup B. P., Royston D., Sapsford R. N., Taylor K. M. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989 Mar;97(3):364–372. [PubMed] [Google Scholar]
  4. Cottam S., Hunt B., Segal H., Ginsburg R., Potter D. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1933–1933. [PubMed] [Google Scholar]
  5. Dietrich W., Barankay A., Dilthey G., Henze R., Niekau E., Sebening F., Richter J. A. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application--clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surg. 1989 Apr;37(2):92–98. doi: 10.1055/s-2007-1013915. [DOI] [PubMed] [Google Scholar]
  6. Dietrich W., Spannagl M., Jochum M., Wendt P., Schramm W., Barankay A., Sebening F., Richter J. A. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology. 1990 Dec;73(6):1119–1126. doi: 10.1097/00000542-199012000-00009. [DOI] [PubMed] [Google Scholar]
  7. Fraedrich G., Weber C., Bernard C., Hettwer A., Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results. Thorac Cardiovasc Surg. 1989 Apr;37(2):89–91. doi: 10.1055/s-2007-1013914. [DOI] [PubMed] [Google Scholar]
  8. Himmelreich G., Kierzek B., Neuhaus P., Slamer K. J., Riess H. Fibrinolytic changes and the influence of the early perfusate in orthotopic liver transplantation with intraoperative aprotinin treatment. Transplant Proc. 1991 Jun;23(3):1936–1937. [PubMed] [Google Scholar]
  9. Kang Y., De Wolf A. M., Aggarwal S., Campbell E., Martin L. K. In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1934–1935. [PubMed] [Google Scholar]
  10. Ketterl R., Haas S., Heiss A., Fritsche H. M., Lechner F., Kienzle H., Blümel G. Zur Wirkung des natürlichen Proteinaseninhibitors Aprotinin auf die Plättchenfunktion beim alloarthroplastischen Hüftgelenkersatz. Med Welt. 1982 Apr 2;33(13):480–486. [PubMed] [Google Scholar]
  11. Mallett S., Rolles K., Cox D., Burroughs A., Hunt B. Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1931–1932. [PubMed] [Google Scholar]
  13. Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987 Dec 5;2(8571):1289–1291. doi: 10.1016/s0140-6736(87)91190-1. [DOI] [PubMed] [Google Scholar]
  14. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth. 1992 Feb;6(1):76–100. doi: 10.1016/1053-0770(91)90052-u. [DOI] [PubMed] [Google Scholar]
  15. Royston D. The serine antiprotease aprotinin (Trasylol): a novel approach to reducing postoperative bleeding. Blood Coagul Fibrinolysis. 1990 Mar-Apr;1(1):55–69. [PubMed] [Google Scholar]
  16. Tzonos T., Giromini D. Aprotinin for intraoperative haemostasis. Neurosurg Rev. 1981;4(4):193–194. doi: 10.1007/BF01743710. [DOI] [PubMed] [Google Scholar]
  17. van Oeveren W., Jansen N. J., Bidstrup B. P., Royston D., Westaby S., Neuhof H., Wildevuur C. R. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987 Dec;44(6):640–645. doi: 10.1016/s0003-4975(10)62153-4. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES